1. Revolutionary, Lifesaving Immunotherapy Takes Significant Step Toward FDA Approval

    Today is a very significant day in the progress toward cancer cures. An advisory committee of the U.S. Food & Drug Administration (FDA) unanimously recommended approval of a revolutionary new treatment for patients with relapsed/refractory acute lymphoblastic leukemia (ALL) – an immunotherapy called CAR-T (chimeric antigen receptor T-cell) immunotherapy. The Leukemia & Lymphoma Society recognized the early promise of this new approach, which uses the body’s own immune system to...

    Read More
  2. The Fruits of Our Funding

    Advances in cancer research seem to be occurring at dizzying speed these days. In just the past three years, we’ve seen a plethora of new therapies approved to treat patients with chronic lymphocytic leukemia and multiple myeloma. And the rapidly advancing field of cancer immunotherapy has produced several novel approaches to treat cancer patients by activating their own immune systems to fight the cancer. Meanwhile, as we learn more about the underlying causes of cancer, scientists are ...

    Read More
  3. When you just need to talk

    Remembering how I needed to talk... Whether you’re a patient or a caregiver, whether you’re coming to grips with a recent diagnosis or you’ve been fighting these battles for years, there are a lot of layers and feelings to this experience. There’s a lot to process, a lot to keep track of, and hopefully some little victories to celebrate along the way. I know this because I remember when my Mom had stage 4 non-hodgkins lymphoma - from the day she got the call to come in for a bi...

    Read More